SunLink Enterprise Value Over E B I T D A from 2010 to 2025
| SSY Stock | USD 0.96 0.09 8.61% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (222.11) | Current Value (211.00) | Quarterly Volatility 79.62490316 |
Check SunLink Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SunLink Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 855 or Total Revenue of 27.7 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 2.54. SunLink financial statements analysis is a perfect complement when working with SunLink Health Valuation or Volatility modules.
SunLink | Enterprise Value Over E B I T D A |
Latest SunLink Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of SunLink Health Systems over the last few years. It is SunLink Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SunLink Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
SunLink Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (19.35) | |
| Coefficient Of Variation | (411.46) | |
| Mean Deviation | 49.30 | |
| Median | 4.82 | |
| Standard Deviation | 79.62 | |
| Sample Variance | 6,340 | |
| Range | 300 | |
| R-Value | (0.61) | |
| Mean Square Error | 4,277 | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | (10.18) | |
| Total Sum of Squares | 95,102 |
SunLink Enterprise Value Over E B I T D A History
About SunLink Health Financial Statements
SunLink Health investors use historical fundamental indicators, such as SunLink Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SunLink Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (222.11) | (211.00) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.